Methods and compositions of novel triazine compounds
申请人:Timmer T. Richard
公开号:US20070099874A1
公开(公告)日:2007-05-03
The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.
Method of promoting nail growth using thyromimetic compounds
申请人:Doherty Niall S.
公开号:US20110098303A1
公开(公告)日:2011-04-28
The present invention provides methods and compositions for increasing the rate of nail growth in mammals, especially humans, using thyromimetic compounds.
TETRAHYDRO-BENZOIMIDAZOLYL MODULATORS OF TGR5
申请人:Janssen Pharmaceutica NV
公开号:US20170029381A1
公开(公告)日:2017-02-02
The present invention comprises compounds of Formula (I).
wherein:
R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, X, Z
1
and Z
2
are defined in the specification.